TABLE 3.
Virus | Strain | No. of samples | No. (% sensitivity) of positive samples by ICT (company): |
|||
---|---|---|---|---|---|---|
Rida Quick Rota/Adeno/Noro Combi (R-Biopharm) | bioNexia Noro/Rota-Adeno (bioMérieux) | Rota+Adeno+Noro Combo Card (CerTest Biotec) | Immunoquick NoRotAdeno (Biosynex) | |||
Group A rotavirus | G1P[8] | 10 | 10 (100) | 10 (100) | 10 (100) | 10 (100) |
G2P[4] | 8 | 8 (100) | 8 (100) | 8 (100) | 7 (87.5) | |
G3P[8] | 5 | 5 (100) | 5 (100) | 5 (100) | 5 (100) | |
G4P[8] | 5 | 5 (100) | 5 (100) | 5 (100) | 5 (100) | |
G9P[8] | 7 | 7 (100) | 7 (100) | 7 (100) | 7 (100) | |
G12P[8] | 5 | 5 (100) | 5 (100) | 5 (100) | 5 (100) | |
G-UDP-UDa | 3 | 0 | 0 | 0 | 1 (33.3) | |
Total | 43 | 40 (93) | 40 (93) | 40 (93) | 40 (93) | |
Nonenteric adenovirus | B | 3 | 0 | 0 | 0 | 0 |
C | 14 | 4 (28.6) | 4 (28.6) | 5 (35.7) | 5 (35.7) | |
D | 1 | 0 | 0 | 0 | 0 | |
Total | 18 | 4 (22.2) | 4 (22.2) | 5 (27.8) | 5 (27.8) | |
Enteric adenovirus | F | 26 | 21 (80.8) | 21 (80.8) | 22 (84.6) | 22 (84.6) |
Untypeable adenovirus | UDa | 2 | 0 | 0 | 0 | 0 |
Total adenovirus, all species | 46 | 25 (54.3) | 25 (54.3) | 27 (58.7) | 27 (58.7) | |
Norovirus genogroup I | GI.1 | 4 | 4 (100) | 0 | 0 | 0 |
GI.2 | 4 | 4 (100) | 4 (100) | 1 (25) | 3 (75) | |
GI.4 | 4 | 3 (75) | 0 | 1 (25) | 0 | |
GI.6[PNA1] | 4 | 4 (100) | 1 (25) | 0 | 0 | |
GI.7 | 4 | 3 (75) | 1 (25) | 0 | 0 | |
Total | 20 | 18 (90) | 6 (30) | 2 (10) | 3 (15) | |
Norovirus genogroup II | GII.2[P16] | 3 | 2 (66.7) | 1 (33.3) | 1 (33.3) | 1 (33.3) |
GII.3 | 1 | 0 | 0 | 0 | 0 | |
GII.4 Sydney[P4 New Orleans] | 4 | 4 (100) | 3 (75) | 4 (100) | 3 (75) | |
GII.4 Sydney[P16] | 4 | 4 (100) | 4 (100) | 4 (100) | 3 (75) | |
GII.6[P7] | 4 | 4 (100) | 2 (50) | 4 (100) | 4 (100) | |
GII.17 | 4 | 3 (75) | 3 (75) | 3 (75) | 3 (75) | |
Total | 20 | 17 (85) | 13 (65) | 16 (80) | 14 (70) | |
Total norovirus genogroups I and II | 40 | 35 (87.5) | 19 (47.5) | 18 (45) | 17 (42.5) |
UD, undetermined.